Oncofreezing is a project which involves a reimbursement by the mandatory health insurance concerning the collection, freezing and conserving of gametes or gonadal tissue prior to an anticancer treatment or prior to a preventive oophorectomy. This is done in order to safeguard the possibility of procreation of the patients who might want to make use of medically assisted procreation or the re-implantation of gonadal tissue in a later life phase.

For the support of Oncofreezing, a convention is agreed upon between RIZIV-INAMI and the care centres.

The objective of the Oncofreezing registry is to record data of patients who are eligible for reimbursement of the medical acts as defined by the convention, i.e. data concerning the collection, freezing and conservation of gametes or gonadal tissue and the outcome.

No additional information available

Les bénéficiaires visés par la convention sont :

1. des patients devant subir un schéma thérapeutique incluant des produits potentiellement gonadotoxiques pour l’une des indications suivantes:

• affection néoplasique d’un organe (tumeur solide cancéreuse) ;
• affection maligne hématopoïétique ou ganglionnaire (leucémie, lymphome, myélome multiple, …) ;

2. des patientes porteuses d’une mutation génétique devant subir une ovariectomie préventive à cause d’un haut risque de cancer mammaire ou de cancer ovarien

No information available

No additional information available